Perspective Therapeutics, Inc. — Director's Dealing 2016

Jun 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2016-06-21

Reporting Person: LAVOY THOMAS C (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-21	Stock Option (Right to Buy)	$0.93	A	100000	Acquired	2026-06-21	Common Stock (100000)	Direct

Footnotes

F1: (1) 1/5 will vest on each anniversary of the grant date, commencing on 6/21/2017, until fully vested.